Monday, May 19, 2025
LBNN
  • Business
  • Markets
  • Politics
  • Crypto
  • Finance
  • Energy
  • Technology
  • Taxes
  • Creator Economy
  • Wealth Management
  • Documentaries
No Result
View All Result
LBNN

CDISC is Proud to Announce a Research Collaboration to Incorporate FDA Business Rules into CDISC’s Open Rules Engine (CORE)

Simon Osuji by Simon Osuji
January 17, 2024
in Politics
0
CDISC is Proud to Announce a Research Collaboration to Incorporate FDA Business Rules into CDISC’s Open Rules Engine (CORE)
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

AUSTIN, Texas–(BUSINESS WIRE)–CDISC is proud to announce a research collaboration with the U.S. Food and Drug Administration’s Office of Translational Sciences in the Center for Drug Evaluation and Research and Office of Regulatory Operations in the Center for Biologics Evaluation and Research to incorporate FDA Business Rules into CDISC’s Open Rules Engine (CORE).


CDISC’s CORE project provides an open-source version of the CDISC Conformance Rules in a machine-executable format. These rules, published and managed by CDISC, create a single source for conformance rules and allow external vendors and sponsor companies to implement and extend these rules within their tools. FDA Business Rules are currently written in a plain text, non-machine executable format and describe the business requirements for regulatory review to help ensure that clinical trial study data is compliant and useful and supports meaningful review and analysis.

The goal of this effort, which began on November 3rd, 2023 and has term of three (3) years, is to collaborate on providing input on machine-executable formats of the FDA Business Rules and on the development and ongoing governance of this set of executable rules within CORE that can be used by sponsors of medical product applications.

“CDISC is grateful for the opportunity to partner with CDER and CBER to establish a single source for machine-executable Conformance Rules and drive the implementation by the industry,” said Peter Van Reusel, Chief Standards Officer at CDISC.

The benefits of creating a single comprehensive and credible source of validation rules include increasing access, transparency, and visibility of validation rules used to ensure the quality and usability of study data in FDA. This will enable sponsors to submit high quality study data that will be ready for regulatory review saving time and effort for all parties involved.

“Our research collaboration with CDISC is an important step to ensure that study data validation rules are understandable and accessible to all,” said Lilliam Rosario, Ph.D., Director, Office of Computational Science, Office of Translational Sciences, CDER.

About CDISC

Clinical Data Interchange Standards Consortium (CDISC) is a global non-profit organization that develops and advances data standards of the highest quality to transform incompatible formats, inconsistent methodologies, and diverse perspectives into a robust framework for generating accessible clinical research data. Driven by the belief that the true measure of data is its impact, CDISC convenes a global community of research experts representing a range of experiences and backgrounds to harness the collective power to drive more meaningful clinical research.

Contacts

Melissa Kirwin

mkirwin@cdisc.org

Source link

Related posts

Trump Administration Should Engage with Africa

Trump Administration Should Engage with Africa

May 19, 2025
How the World Bank is tackling the growing global waste crisis

How the World Bank is tackling the growing global waste crisis

May 19, 2025
Previous Post

My Pivot Journal: Jennifer Daniel’s exciting journey from Talent Management to Product Design

Next Post

MONUSCO’s Gradual Departure Poses Risk to DRC Civilians, Remaining Forces

Next Post
MONUSCO’s Gradual Departure Poses Risk to DRC Civilians, Remaining Forces

MONUSCO’s Gradual Departure Poses Risk to DRC Civilians, Remaining Forces

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

RECOMMENDED NEWS

Why Analysts Still Predict SOL to Reach $260

Why Analysts Still Predict SOL to Reach $260

9 months ago
Urgent grid reform needed for battery storage, NatPower UK says

Urgent grid reform needed for battery storage, NatPower UK says

6 months ago
US Congressman Says SEC Chair is Set on “Sabotaging” Crypto

US Congressman Says SEC Chair is Set on “Sabotaging” Crypto

2 years ago
Evidence of High Amounts of Corporate Data Circulating the Dark Web – IT News Africa

Evidence of High Amounts of Corporate Data Circulating the Dark Web – IT News Africa

1 year ago

POPULAR NEWS

  • Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

    0 shares
    Share 0 Tweet 0
  • When Will SHIB Reach $1? Here’s What ChatGPT Says

    0 shares
    Share 0 Tweet 0
  • Matthew Slater, son of Jackson State great, happy to see HBCUs back at the forefront

    0 shares
    Share 0 Tweet 0
  • Dolly Varden Focuses on Adding Ounces the Remainder of 2023

    0 shares
    Share 0 Tweet 0
  • US Dollar Might Fall To 96-97 Range in March 2024

    0 shares
    Share 0 Tweet 0
  • Privacy Policy
  • Contact

© 2023 LBNN - All rights reserved.

No Result
View All Result
  • Home
  • Business
  • Politics
  • Markets
  • Crypto
  • Economics
    • Manufacturing
    • Real Estate
    • Infrastructure
  • Finance
  • Energy
  • Creator Economy
  • Wealth Management
  • Taxes
  • Telecoms
  • Military & Defense
  • Careers
  • Technology
  • Artificial Intelligence
  • Investigative journalism
  • Art & Culture
  • Documentaries
  • Quizzes
    • Enneagram quiz
  • Newsletters
    • LBNN Newsletter
    • Divergent Capitalist

© 2023 LBNN - All rights reserved.